The global sarcopenia treatment market is gaining steady momentum as aging populations, rising awareness of muscle-wasting disorders, and advances in medical nutrition and therapeutics converge to address a growing unmet need. Sarcopenia, characterized by the progressive loss of skeletal muscle mass and strength, is increasingly recognized as a serious public health concern due to its association with frailty, falls, disability, and reduced quality of life among older adults. Healthcare systems worldwide are prioritizing early diagnosis and intervention, while pharmaceutical and biotechnology companies are accelerating research into disease-modifying therapies. As a result, the market is transitioning from supportive care approaches toward more targeted, evidence-based treatment strategies that integrate nutrition, exercise, and pharmacological innovation.
Access key findings
and insights from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28547
Market Size and Growth
In 2024, the global sarcopenia treatment market was valued
at US$ 2.8 billion, reflecting growing adoption of nutritional supplements,
hormonal therapies, and emerging drug candidates. Looking ahead, the market is
projected to reach US$ 4.7 billion by 2035, expanding at a compound
annual growth rate (CAGR) of 4.9% from 2025 to 2035. This consistent growth
trajectory is driven by demographic shifts, particularly the rapid expansion of
the elderly population across developed and emerging economies. Additionally,
increasing healthcare expenditure, improved screening for age-related
disorders, and favorable regulatory support for geriatric care solutions are
reinforcing long-term market expansion.
Market Segmentation
The sarcopenia treatment market can be segmented by
treatment type, route of administration, and end user. Treatment-wise,
nutritional interventions—including protein supplements, amino acids, and
vitamin D—continue to dominate due to their accessibility and preventive
benefits. Pharmacological therapies, such as anabolic agents, myostatin
inhibitors, and anti-inflammatory drugs, represent a rapidly evolving segment
as clinical pipelines mature. By route of administration, oral therapies hold
the largest share, supported by patient compliance and chronic use suitability,
while injectable therapies are gaining attention for advanced and severe cases.
End users primarily include hospitals, specialty clinics, rehabilitation
centers, and homecare settings, reflecting the long-term and multidisciplinary
nature of sarcopenia management.
Regional Analysis
Regionally, North America leads the global market, supported
by strong healthcare infrastructure, high awareness levels, and active clinical
research. Europe follows closely, driven by aging demographics and
government-backed elderly care initiatives. The Asia-Pacific region is expected
to witness the fastest growth over the forecast period, fueled by rapidly aging
populations in countries such as Japan and China, rising healthcare
investments, and expanding access to nutritional and pharmaceutical
interventions. Meanwhile, Latin America and the Middle East & Africa are
emerging markets, gradually adopting sarcopenia-focused treatments as awareness
and diagnostic capabilities improve.
Competitive Landscape
The competitive landscape is characterized by a mix of
global pharmaceutical leaders, nutrition specialists, and innovative
biotechnology firms. Key players shaping the market include Nestlé Health
Science, Abbott Nutrition, Eli Lilly and Company, Pfizer
Inc., Amgen Inc., Biophytis, TNF Pharmaceuticals, Epirium
Bio, Turn Biotechnologies, Inc., ONCOCROSS CO., LTD, BPGbio,
Inc., Lipocine, Rejuvenate Biomed NV, and Animuscure Co.,
Ltd. These organizations are focusing on clinical trials, strategic
partnerships, and novel therapeutic mechanisms to gain competitive advantage.
About
Transparency Market Research
Transparency Market Research, a global market research company registered
at Wilmington, Delaware, United States, provides custom research and consulting
services. Our exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insights for thousands of decision makers. Our
experienced team of Analysts, Researchers, and Consultants use proprietary data
sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of
research experts, so that it always reflects the latest trends and information.
With a broad research and analysis capability, Transparency Market Research
employs rigorous primary and secondary research techniques in developing
distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453